William Ackman’s Pershing Square Capital Management LP cut its stake in Valeant Pharmaceuticals International Inc. to help generate a loss for tax purposes.
The New York activist hedge fund, which has stumbled as its hefty bet on Valeant has been hammered, sold about 3.5 million shares of the company
to generate the loss, according to a securities filing. That lowered its stake to 7.8% from 9%.
View more information: https://www.marketwatch.com/story/pershing-square-sells-some-valeant-stock-seeking-a-tax-loss-2016-12-14